About the Course

The 2024 Fundamentals of HCT Training Course is a two-day course that was held virtually on Friday, April 19 - Saturday, April 20, 2024.

The Fundamentals of HCT Training Course provides a broad overview and introduction of hematopoietic cell transplantation (HCT), as well as cellular immunotherapy (CI). Throughout the lectures, participants are introduced to numerous aspects of the HCT-CI processes, which are designed to develop or enhance skills required in the management of patients undergoing these procedures. This course incorporates case-based learning to emphasize application of concepts taught through didactic lecture with a strong focus on pharmacotherapeutic management. 

Who Should Attend

  • Advanced Practice Providers
  • Fellows
  • In-Training Professionals
  • New Practitioners
  • Pharmacists
  • Physicians
  • Nurses

Key Information

  • Deadline to register: April 18, 2024 at 5 PM CT
  • Attendees can earn up to 15.25 CE for sessions attended in real-time
  • Access session recordings through May 20, 2024

Registration Rates
Type Price
ASTCT Member Rate $300
Non-Member Rate $425
Fellow/Trainee Rate $250
Low-Middle Income Countries Rate* $15
Registration with 50% off the 2023 eBook* Add $150 to your respective registration type 

*Only eligible for registrants currently practicing and residing in a low-middle income country as classifed by the World Bank here.

*With this add-on, you will receive access to the 2023 Fundamentals of HCT eBook a week prior to the course. Please advise that the eBook is NOT required to attend the meeting or participate in any of the live sessions.

Attendees will have access to the virtual platform until May 20, 2024, to review recordings, but please note that to obtain ACPE credit, AMA PRA Category 1 Credit(s), and ANCC contact hours, you must attend the live sessions on April 19-20, 2024. Recordings are only available to view on the virtual platform. Attendees are unable to download the session recordings for personal viewing, but you will be able to download PDFs of speaker slides. Please review the full accreditation information at the bottom of this page for instructions on participation and requesting credit.

Registration for the meeting closed on Thursday, April 18 at 5 p.m. CT. Please contact info@astct.org with any questions about registration. 

Cancellation Policy

Registered attendees will have access to the recordings until May 20, 2024. Therefore, ASTCT will not be refunding any registrations to the 2024 virtual Fundamentals of HCT Training Course. Registration payments are non-transferable.

Agenda

Day 1: Friday, April 19 (CDT)
Time Topic
8:00 – 8:10 AM
(10 mins)		 Welcome & Opening Remarks
Susie Long, PharmD; University of Minnesota, Minneapolis, MN
8:10 – 8:40 AM
(30 mins)		 Introduction to Hematopoietic Stem Cell Transplant
Jason Ernstberger, PharmD, BCOP; University of Cincinnati Medical Center, Cincinnati, OH
8:45 – 9:30 AM
(45 mins)		 Pre-Transplant Evaluation
Andrea Fadel, BSN, RN, OCN, BMTCN; University of Chicago Medicine, Chicago, IL
9:35 – 10:35 AM
(60 mins)		 Donor Selection Debate
Shatha Farhan, MD; Henry Ford Health, Detroit, MI
Ioannis Politikos, MD; Memorial Sloan Kettering Cancer Center, New York City, NY
Marco Ruiz, MD; Baptist Health Miami Cancer Institute, Miami, FL
10:35 – 10:45 AM
(10 mins)		 Break
10:45 – 11:30 AM
(45 mins)		 Hematopoietic Stem Cell Mobilization
Erika Wass, PharmD, BCOP; Loma Linda University Medical Center, Loma Linda, CA
11:35 – 12:35 PM
(60 mins)		 Principles of Conditioning in Hematopoietic Stem Cell Transplant
Taiga Nishihori, MD; Moffitt Cancer Center, Tampa, FL
12:35 – 1:05 PM
(30 mins)		 Lunch
1:05 – 2:05 PM
(60 mins)		 Special Populations in HCT: Pediatrics + Patient Case
Susie Long, PharmD; University of Minnesota, Minneapolis, MN		 Special Populations in HCT: Geriatrics + Patient Case
Andrew Artz, MD; City of Hope, Los Angeles, CA
2:10 – 3:25 PM
(75 mins)		 Supportive Care for Peri-Transplant Complications
Amber Clemmons, PharmD, BCOP; University of Georgia, Augusta, GA
3:25 – 3:35 PM
(10 mins)		 Break
3:35 – 4:20 PM
(45 mins)		 Transplant Associated Thrombotic Microangiopathy
Hemalatha Rangarajan, MD; Nationwide Children's Hospital, Columbus, OH		 Pulmonary Complications of HCT
Suzanne Gettys, PharmD, BCOP; MD Anderson Cancer Center, Houston, TX
4:25 – 4:55 PM
(30 mins)		 Patient Case: Veno Occlusive Disease/ Sinusoidal Obstructive Syndrome
Katie Gatwood, PharmD, BCOP; Vanderbilt University, Nashville, TN
5:00 – 5:30 PM
(30 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)
Day 2: Saturday, April 20 (CDT)
Time Topic
8:00 – 9:00 AM
(60 mins)		 Viral Infections in Hematopoietic Stem Cell Transplant
LeAnne Kennedy, PharmD, BCOP; Wake Forest University, Winston-Salem, NC
9:05 – 9:50 AM
(45 mins)		 Fungal Infections in Hematopoietic Stem Cell Transplant
Arpita Gandhi, PharmD, BCOP; Emory Healthcare - Winship Cancer Institute, Atlanta, GA
9:55 – 10:55 AM
(60 mins)		 Patient Case: Navigating Cytopenia Post Transplant
Forat Lufti, MD; University of Kansas Medical Center, Kansas City, KS
10:55 – 11:05 AM
(10 mins)		 Break
11:05 – 12:20 PM
(75 mins)		 Acute Graft vs Host Disease
Elizabeth DiMaggio, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
12:20 – 12:50 PM
(30 mins)		 Lunch
12:50 – 2:05 PM
(75 mins)		 Chronic Graft vs Host Disease
Rebecca Gonzalez, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
2:05 – 2:15 PM
(10 mins)		 Break
2:15 – 3:00 PM
(45 mins)		 Patient Case: Engraftment Syndrome
Brooke Adams, PharmD, BCOP; University of Florida Health Shands, Gainesville, FL		 Patient Case: Steroid Refractory GVHD
Molly Gallogly, MD, PhD; Case Comprehensive Cancer Center, Cleveland, OH
3:05 – 3:50 PM
(45 mins)		 Immune Effector Cell Products and Indications
Jennifer Collins, PharmD, BCOP; University of Chicago Medicine, Chicago, IL
3:55 – 4:55 PM
(60 mins)		 Management of Immune Effector Cell Toxicity and Complications
Cameron Ninos, PharmD, BCOP; University of Wisconsin – Madison, Madison, WI
4:55 – 5:05 PM
(10 mins)		 Break
5:05 – 5:30 PM
(25 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)

Accredited Provider

This activity is jointly provided by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). Attendees can earn up to 15.25 continuing education credits or hours.

 

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION

The France Foundation designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

The France Foundation designates this activity for 15.25 contact hours.

PHARMACISTS

This knowledge and application-based activity qualifies for 15.25 contact hours (0.1525 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net)

All other healthcare professionals completing this course will be issued a statement of participation.

COURSE SYLLABUS

To view all course accreditation information, please download the course syllabus.

COURSE SYLLABUS

DISCLOSURE POLICY
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and ASTCT resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ASTCT seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ASTCT are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Disclosures for members of the planning committee and faculty can be viewed here.

DISCLOSURES

Disclosure of Unlabeled Use:
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational. They must also disclose limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off label use of these medications. TFF and ASTCT do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

ASTCT is not seeking commercial support to assist in funding this live education opportunity.

Disclaimer
The France Foundation and the American Society for Transplantation and Cellular Therapy present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, The American Society for Transplantation

CONTACT INFORMATION
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.